Access cutting-edge diffuse large b-cell lymphoma treatment through this clinical trial at a research site in Anchorage. Study-provided care at no cost to qualified participants.
Access diffuse large b-cell lymphoma specialists in Anchorage at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diffuse large b-cell lymphoma treatment provided free
The main goal of this trial is to study the frequency and severity of cytokine release syndrome (CRS) in participants with diffuse large B-cell lymphoma (DLBCL) who are using a combination of glofitamab + gemcitabine + oxaliplatin (Glofit-GemOx) followed by glofitamab-only treatment.
Sponsor: Hoffmann-La Roche
Check if you qualify for this diffuse large b-cell lymphoma clinical trial in Anchorage, AK
If you're searching for diffuse large b-cell lymphoma treatment options in Anchorage, AK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anchorage research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diffuse large b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.